Member Info for jmfw

Published 10/20, but Elsevier received 6 March 2020, Revised 15 May 2020, Accepted 17 May 2020, Available online 24 May 2020

Unfortunately, at this moment, the 'bot' is taking the sp down https://www.nasdaq.com/market-activity/stocks/tlsa/real-time
Let's hope it has a change of mood sooner rather than later.

Whimax, agree. Posted similar sentiment in September.

Last 2 days of trading shorts had 22% & 26% of the volume. Close of play 30 September total short position was in excess of 625k shares, which was the most recorded over the previous 12 months.
Doesn't matter what happens on AIM, at the moment we are governed by the Nasdaq. Let's hope the immediate run-in to the split provides some positive action.

Has been common to several promising investments. Avacta, Tiziana, Omega, Novacyt & several other 'sound' stocks have endured same fate, but look where they are now. The options are clear, hold if you have faith in the company, sell if not, or trade the waves that will undoubtedly occur. Extreme emotions can be experienced when investing on AIM.

Both links below indicate employee:
https://www.sec.gov/Archives/edgar/data/1415016/000119312507220537/dex101.htm
https://www.nibusinessinfo.co.uk/content/defining-share-option-and-share-award-schemes

If so, are they thinking of selling?

Could be they're hoping they can announce something positive (timelines etc) re rollout of our (hopefully) test. In which case good for avct investors.

$4.10, but on VERY small volume https://www.marketwatch.com/investing/stock/tlsa
However, it could indicate the direction of travel we could be taken today. Onward & upward, hopefully.

Not registered with Linkedin. What does the Bruker post have to say? Thanks

When suggesting the Main Market I'm not referring to the ftse 100, nor the Premium Main Market, only the Standard Main Market, where there has to be a minimum valuation of £700k.
We all know AIM is the 'wild west' & probably lacks the credibility of the Main Market. Unless there are good reasons to remain on AIM (& there are a couple) the Main Market would offer a quicker route to the Prmium Market.
For info https://www.valuethemarkets.com/2018/02/26/aim-listing-vs-standard-listing-main-market-whats-difference/

Wouldn't it be wise, in the near term, to transfer from AIM to our main market?

Very likely post Monday's event

If 3 of the 4 are SD Biosensor, Healgen & Innova, they are not British, but more importantly are not 'quoted' coys. Could explain the silence re the 4th (Avacta being listed).

Think.....you were really keen yesterday " can see just the opposite happening and Deep Verge buying Avacta in the future,
Looking ahead to next year, Brandon is keen to make an even larger acquisition to bolster its distribution channels.
https://www.yorkshirepost.co.uk/business/life-sciences-chief-who-has-become-covid-water-detective-2976660"

What Integum's rns indicates to me is that without affimers (or aptamers) their offering is unable to detect anything. It does confirm the affimers must work well if they can detect the virus from a breath test.

Not sure they update the site that often (except for rns). 2 vacancies have a closing date of 31 Aug, the other 27 July. If the news item you refer to is from the investors page, then it's dated 6 Aug, & plenty since then. So while site revamped certain aspects appear not up to date.

Close $3.92 with 'after hours' showing $3.77. Big trade recorded just before close (15.58) 10,011 shares. Looks a buy.

I'm interested to discover the total 'short' for today. Hopeful that bottom of retrace is behind us (joke in there somewhere) but who knows while 'shorts'/manipulation dictates. However, pretty confident new year will see us much happier.

Whimax re yr earlier post. For info the site I forwarded does also include live trades: https://www.nasdaq.com/market-activity/stocks/tlsa/latest-real-time-trades

Good man. What questions will you ask to 'flush him out'?